HQLTekla Life Sciences Investors
22.38USD-1.28%Mkt Cap: 680.53M $P/E: 3.373d ago
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the…
Industry Peers
Asset ManagementKey Statistics
Company
Market Cap680.53M $
Enterprise Value670.56M $
Revenue (TTM)1.11M $
Gross Profit1.11M $
Net Income (TTM)85.59M $
Revenue/Share0.0360 USD
Last Price22.38 USD
Fiscal Year EndSep 2025
MR QuarterMar 2026
Employees—
CountryUS
SectorFinancial Services
IndustryAsset Management
ISIN—
Valuation
P/E (Trailing)3.37
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue604.24
P/S—
P/B1.20
EPS (TTM)6.47
EPS (Forward)—
52W Range
13.5797% of range22.67
52W High22.67 USD
52W Low13.57 USD
Profitability
Gross Margin100.00%
Oper. Margin-516.53%
EBITDA Margin0.00%
Profit Margin99.08%
ROE16.66%
ROA16.61%
Growth
Revenue Growth-60.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF31.71M $
CapEx (TTM)—
FCF Margin-392.20%
FCF Yield-0.64%
Net Debt-851.60K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.61
Quick Ratio1.55
Book Value/Sh18.44 USD
Cash/Share0.0280 USD
Dividends
Fwd Div Rate2.240 USD
Trail. Div Rate1.910 USD
Div. Yield10.14%
5Y Avg Yield10.69%
Payout Ratio28.77%
Ex-Div DateAug 24, 2026
Pay DateDec 31, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.41M
Float—
Insiders0.00%
Institutions26.47%
Short Interest
Short Ratio0.1d
Short % Out.0.06%
Shares Short62.73K
Short (prev mo.)14.27K
Technical
SMA 5019.67 (+13.8%)
SMA 20017.70 (+26.4%)
Beta0.71
S&P 52W Chg18.16%
Avg Vol (30d)159.01K
Avg Vol (10d)175.16K
Technical Indicators
RSI (14)75.1
MACD0.6987
MACD Signal0.4827
MACD Hist.+0.2160
BB Upper22.53 USD
BB Middle20.34 USD
BB Lower18.16 USD
BB Width21.47%
ATR (14)0.4946 USD
Vol Ratio (20d)0.98x